LEADER 03615nam  22006135  450 
001 9910357827303321
005 20200703070042.0
010   $a981-15-0910-7
024 7 $a10.1007/978-981-15-0910-0
035   $a(CKB)4100000009837030
035   $a(DE-He213)978-981-15-0910-0
035   $a(MiAaPQ)EBC5975932
035   $a(PPN)242824315
035   $a(EXLCZ)994100000009837030
100   $a20191108d2019      u|             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCarbon Nanotubes for Targeted Drug Delivery$b[electronic resource] /$fby Md Saquib Hasnain, Amit Kumar Nayak
205   $a1st ed. 2019.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2019.
215   $a1 online resource (XIV, 106 p. 21 illus., 16 illus. in color.)
225 1 $aSpringerBriefs in Applied Sciences and Technology,$x2191-530X
311   $a981-15-0909-3 
320   $aIncludes bibliographical references.
327   $aIntroduction -- Chemical and physical properties of Carbon Nanotubes -- Classification of Carbon Nanotubes -- Preparation of Carbon Nanotubes -- Functionalization of Carbon Nanotubes -- Carbon Nanotubes Characterization -- Applications of Carbon Nanotubes -- Carbon Nanotubes absorption and transportation -- Carbon Nanotubes Toxicity Consideration -- Carbon Nanotubes Regulatory considerations -- Carbon Nanotubes Clinical trials and market status -- Conclusion.
330   $aThis book provides a detailed introduction to carbon nanotubes (CNTs) for targeted drug delivery. After a brief overview of the classification, preparation, and characterization of carbon nanotubes, it focuses on their use in targeted drug delivery. It presents CNTs for brain targeting, ocular targeting, cancer targeting, and lymphatic targeting, as well as antibody therapy. The book also includes chapters on carbon nanotubes for controlled drug delivery, transdermal drug delivery, solubility enhancement, vaccine delivery, gene delivery, and as quantum dots. Last but not least, it addresses the absorption and transportation of CNTs, toxicity and regulatory considerations, as well as clinical trials and the market status of CNTs. .
410  0$aSpringerBriefs in Applied Sciences and Technology,$x2191-530X
606   $aNanotechnology
606   $aPharmaceutical technology
606   $aPharmacy
606   $aNanotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/Z14000
606   $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010
606   $aNanotechnology and Microengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T18000
606   $aDrug Safety and Pharmacovigilance$3https://scigraph.springernature.com/ontologies/product-market-codes/H69010
615  0$aNanotechnology.
615  0$aPharmaceutical technology.
615  0$aPharmacy.
615 14$aNanotechnology.
615 24$aPharmaceutical Sciences/Technology.
615 24$aNanotechnology and Microengineering.
615 24$aDrug Safety and Pharmacovigilance.
676   $a620.115
700   $aHasnain$b Md Saquib$4aut$4http://id.loc.gov/vocabulary/relators/aut$0770182
702   $aNayak$b Amit Kumar$4aut$4http://id.loc.gov/vocabulary/relators/aut
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910357827303321
996   $aCarbon Nanotubes for Targeted Drug Delivery$92543129
997   $aUNINA